Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience

2011/08/25 by Inderpal S. Sarkaria, Akira Iyoda, Mee Soo Roh +8 · 25 citations
Medicine · #Neuroendocrine Tumor Research Advances #Lung Cancer Research Studies #Breast Lesions and Carcinomas

paper · pdf · doi:10.1016/j.athoracsur.2011.05.027

Cited by

• Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung. [europepmc]
• Treatment options for patients with large cell neuroendocrine carcinoma of the lung. [europepmc]
• Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas. [europepmc]
• Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes. [europepmc]
• Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. [europepmc]
• Correlation of neuroendocrine features with prognosis of non-small cell lung cancer. [europepmc]
• Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations. [europepmc]
• The role of surgery in high grade neuroendocrine tumours of the lung. [europepmc]
• Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy. [europepmc]
• A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. [europepmc]
• Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis. [europepmc]
• Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. [europepmc]
• Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung. [europepmc]
• A Semiquantitative Scoring System May Allow Biopsy Diagnosis of Pulmonary Large Cell Neuroendocrine Carcinoma. [europepmc]
• Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis. [europepmc]
• New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. [europepmc]
• Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage. [europepmc]
• Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: a retrospective single-institution analysis and literature review. [europepmc]
• Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities. [europepmc]
• Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches. [europepmc]
• Management of Large Cell Neuroendocrine Carcinoma. [europepmc]
• Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population. [europepmc]
• Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges. [europepmc]
• Pulmonary Large Cell Neuroendocrine Carcinoma. [europepmc]
• The Surgical Management of Lung Neuroendocrine Neoplasms. [europepmc]